MedPath

Ipratropium Bromide

Ipratropium Bromide Nasal Solution 0.06%(Nasal Spray)

Approved
Approval ID

09ab5bc2-645f-415d-ad76-246385690176

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 11, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ipratropium Bromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-355
Application NumberANDA076103
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ipratropium Bromide
Product Specifications
Route of AdministrationNASAL
Effective DateApril 9, 2010
FDA Product Classification

INGREDIENTS (7)

EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
IPRATROPIUM BROMIDEActive
Quantity: 42 ug in 1 1
Code: J697UZ2A9J
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ipratropium Bromide - FDA Drug Approval Details